Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 233

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 233
---
holders. As our needs evolve, we intend to continue to evaluate our philosophy and compensation programs as circumstances require. This section provides an overview of our and Legacy Tvardi’s executive compensation programs, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. This section also sets forth information relating to the compensation earned by Cara’s named executive officers for the fiscal years ended December 31, 2024 and 2023, as well as certain information regarding equity awards granted to Cara’s named executive officers that remained outstanding as of December 31, 2024. The pre-Merger compensation, including equity awards, disclosed below for Cara’s and Legacy Tvardi’s named executive officers has been adjusted to give retroactive effect to the Reverse Stock Split and Exchange Ratio. Unless otherwise indicated, as used in this section, “Tvardi,” the “Company,” “we,” “us” and “our” refer to Legacy Tvardi prior to the closing of the Merger and Tvardi Therapeutics, Inc. after the closing of the Merger. For the year ended December 31, 2024, Legacy Tvardi’s named executive officers were:

| ● | Imran Alibhai, Ph.D., Chief Executive Officer and Director; |

| ● | John Kauh, M.D., Chief Medical Officer; and |

| ● | Dan Conn, J.D., M.B.A., Chief Financial Officer. |

For the year ended December 31, 2024, Cara’s named executive officers were:

| ● | Christopher Posner, President and Chief Executive Officer; |

| ● | Ryan Maynard, Chief Financial Officer; and |

| ● | Scott Terrillion, General Counsel, Secretary and Chief Compliance Officer. |

2024 Summary Compensation Tables The following table presents all of the compensation awarded to or earned by or paid to Tvardi’s named executive officers for their service at Legacy Tvardi prior to the Merger.

| ​                                    
 ​                                    
 ​                                    
 Name and Principal Position          | ​ 
 ​ 
 ​ |    ​ 
    ​ 
    ​ 
 Year | ​ 
 ​ 
 ​ | ​      
 ​      
 Salary 
 ($)    |       ​ 
       ​ | ​      
 ​      
 ​      | ​     
 ​     
 Bonus 
 ($)   |       ​ 
       ​ | ​      
 ​      
 ​      | ​      
 Option 
 awards 
 ($)(1) |       ​ | ​ 
 ​ 
 ​ | ​         
 All other 
 ​